“Unless this cancer-causing weedkiller is banned by the Environmental Protection Agency or Bayer cuts its losses and stops making it, people will continue to be exposed and risk serious illness.”

After a federal judge rejected a $2 billion class-action proposal from Bayer to avert future lawsuits alleging its popular Roundup herbicide causes cancer, the pharmaceutical and chemical giant announced Thursday that it would consider ending sales of the glyphosate-based weedkiller for residential use in the United States.

In a statement, Bayer said that it “will immediately engage with partners to discuss the future of glyphosate-based products in the U.S. residential market” in a move aimed at “mitigating future litigation risk.”

“None of these discussions will affect the availability of glyphosate-based products in markets for professional and agricultural users,” the Germany-based company added. 

On Wednesday, U.S. District Court Judge Vince Chhabria in San Francisco rejected Bayer’s $2 billion plan to settle future lawsuits as “clearly unreasonable,”